SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028022
Filing Date
2022-08-04
Accepted
2022-08-04 16:32:57
Documents
42
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mack-10q_20220630.htm   iXBRL 10-Q 855501
2 EX-31.1 mack-ex311_9.htm EX-31.1 9569
3 EX-31.2 mack-ex312_6.htm EX-31.2 9570
4 EX-32.1 mack-ex321_8.htm EX-32.1 5719
5 EX-32.2 mack-ex322_7.htm EX-32.2 5719
  Complete submission text file 0001564590-22-028022.txt   2846481

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mack-20220630.xsd EX-101.SCH 26341
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20220630_cal.xml EX-101.CAL 19420
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20220630_def.xml EX-101.DEF 52650
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20220630_lab.xml EX-101.LAB 186945
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20220630_pre.xml EX-101.PRE 126427
36 EXTRACTED XBRL INSTANCE DOCUMENT mack-10q_20220630_htm.xml XML 345167
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 221137196
SIC: 2834 Pharmaceutical Preparations